NPM1 and leukemia: Using the most recent RNAseq data published by Bamopoulos et al. [16] we observed that FLT3-like leukemias were highly enriched in concurrent NPM1 and DNMT3A mutants, whereas 19.60% of FLT3-like AMLs were NPM1 and DNMT3A wild-type.